Home Archive Blogs Collections Podcasts Videos Info & Services
Skip Navigation LinksHome > September 10, 2008 - Volume 30 - Issue 17 > FDA Launches Fellowship Program to Develop Pipeline of Scien...
Oncology Times:
doi: 10.1097/01.COT.0000337615.51377.89
In Brief

FDA Launches Fellowship Program to Develop Pipeline of Scientists, Other Professionals

Free Access

The FDA has launched a two-year fellowship program aimed at attracting scientists, engineers, and health professionals to the agency. The program will provide participants with advanced training in the scientific analysis involved in the safety and regulatory decisions unique to the agency's mission, a news release notes.

“Attracting the best scientists to FDA helps us make timely decisions and give doctors and patients helpful and accurate advice about treatment options. And timely decisions encourage more investment in developing new drugs and better medical devices,” Deputy Secretary of Health and Human Services Tevi D. Troy, said in the release.

“The FDA Commissioner's Fellowship Program will not only bring great fellows in the door, but encourage them to make FDA their career.”

Applicants are being considered for the first entering class of the program, which will begin in October. The agency is seeking physicians, microbiologists, chemists, statisticians, pharmacists, biomedical engineers, nutritionists, veterinarians, and other science professionals. Applicants should have a doctoral degree in medicine or another scientific field; engineers must have at least a bachelor's degree. Between 30 and 40 applicants will be accepted for the first entering class.

“The FDA is a science-based regulatory agency, and to fulfill our mission over the coming decade we will need to recruit thousands of highly skilled scientists and others with specialized and relevant expertise,” said Frank M. Torti, MD, MPH, principal deputy commissioner and chief scientist.

“The FDA Commissioner's Fellowship Program is designed to attract these people to the FDA and provide them with in-depth knowledge of the science that underpins regulatory decisions as we meet the challenges of both globalization and rapid changes in science and technology.”

© 2008 Lippincott Williams & Wilkins, Inc.

Login

Article Tools

Share